FDA Coronavirus (COVID-19) Update: July 25th, 2020
July 25, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic Friday, July 24th, 2020.
Coronavirus
FDA Coronavirus (COVID-19) Update: July 24th, 2020
July 24, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Today, the FDA updated the Testing Supply Substitution Strategies slide show.
Coronavirus.
Tennessee Department of Education Releases 2020 Tennessee Educator Survey Responses
July 22, 2020
Nashville, TN – The Tennessee Department of Education released key findings and responses from the 2020 Tennessee Educator Survey.
The Tennessee Educator Survey, conducted annually in partnership with Tennessee Education Research Alliance (TERA), gathers data to understand educator experience to provide direct feedback to stakeholders and policymakers on a series of key issues facing our schools and classrooms.
Majority of Teachers and Leaders in Tennessee Responded; Overview Brief with Key Findings Available
FDA Coronavirus (COVID-19) Update: July 22nd, 2020
July 22, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
A new FDA Voices, tilted FDA’s Ongoing Work to Support and Advance COVID-19 Diagnostic Test Accuracy and Availability, describes how FDA has been proactive and supportive of test development by all comers — including laboratories, and large and small commercial manufacturers — to speed development and to quickly authorize tests that the science supports.
Coronavirus
FDA Coronavirus (COVID-19) Update: July 21th, 2020
July 21, 2020
Silver Spring, MD – The U.S. Food and Drug Administration has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA reissued an Emergency Use Authorization (EUA) to Quest Diagnostics for its Quest SARS-CoV-2 rRT-PCR test, which is now authorized for use with pooled samples containing up to four individual upper-respiratory swab specimens collected under observation.
Coronavirus
Tennessee Governor Bill Lee announces Additional $115 Million for Local Governments to Support COVID-19 Response
July 20, 2020
Nashville, TN – Today, Monday, Julyu 20t, 2020, Tennessee Governor Bill Lee and the Financial Stimulus Accountability Group announced an additional $115 million in Coronavirus Relief Funds will be made available to local governments to offset costs incurred from responding to the COVID-19 Coronavirus pandemic.
Tennessee Governor Bill Lee
FDA Coronavirus (COVID-19) Update: July 18th, 2020
July 18, 2020
Silver Spring, MD – The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
As part of the FDA’s effort to protect consumers, the agency issued warning letters to operators of two websites (www.hydroxychloroquine-online.com and www.pharmaboosters.com) that market unapproved COVID-19 Coronavirus products.
Coronavirus
FDA Coronavirus (COVID-19) Update: July 17th, 2020
July 17, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
At 8:00pm on Friday, July 17th, 2020 the FDA will close its COVID-19 Industry Hotline.
Coronavirus
FDA Coronavirus (COVID-19) Update: July 16th, 2020
July 16, 2020
Silver Spring, MD – The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Today, the Food and Drug Administration (FDA) updated its Frequently Asked Questions on Testing for SARS-CoV-2.
Coronavirus.
FDA Coronavirus (COVID-19) Update: July 15th, 2020
July 15, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA has posted an updated Coronavirus Treatment Acceleration Program (CTAP) webpage. The webpage provides information about CTAP’s purpose, strategy and operations.
Coronavirus
